CoChat

Clinical pharmacy‐led disease and medicine management programme for patients with COPD

Open access
Khdour, Maher R., Kidney, Joseph C., Smyth, Bronagh M., McElnay, James C. · 2009 · British Journal of Clinical Pharmacology
Cited by 145

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • The concept of self‐management plans for patients with chronic obstructive pulmonary disease (COPD) is derived from their success in asthma management. • It is believed that selected people with COPD may benefit from the early intervention that comes from following self‐management plans, which may prevent a crisis and possibly the need for hospital admission. • There is little published information on clinical pharmacist‐led disease and patient self‐management in the area of COPD care. WHAT THIS STUDY ADDS • A structured education programme led by a clinical pharmacist for patients with COPD was associated with a reduction in both hospitalization and emergency department visits and an improvement in patients' adherence to treatment regimens and health‐related quality of life (excluding physical activity). • The intervention programme was tailored and individualized based on a preliminary assessment of individual patient needs. • Education about self‐management in COPD patients should be explicit, tailored to individual needs, and on a continuous basis. AIM: The aim was to investigate the impact of a disease and medicine management programme, focusing on self‐management in patients with chronic obstructive pulmonary disease (COPD). METHODS: One hundred and seventy‐three patients (mean age 67 years; 54% female) were recruited; 86 patients were randomly assigned to an intervention group and 87 to a usual care (control) group. Intervention patients received education on disease state, medications and breathing techniques. Patients were given booklets and a customized action plan (antibiotic and oral steroid to be initiated promptly by patients for exacerbations). Patients were followed up at 6 and 12 months during a scheduled visit. The St George's Respiratory Questionnaire (SGRQ), COPD Knowledge and Morisky adherence questionnaires were administered to all patients at baseline, 6 and 12 months. Outcome measures included hospital admissions, emergency department (ED) visits, health‐related quality of life (HRQoL) and medication adherence. RESULTS: Over the 12‐month period in the intervention group, ED visits decreased by 50% (P= 0.02) and hospitalization by approximately 60% (P= 0.01). On the SGRQ, differences reached statistical significance on the symptom (−7.5; P= 0.04) and impact (−7.4; P= 0.03) subscales but not on the physical activity subscale. There was a significant difference between the intervention and usual care groups regarding knowledge scores (75.0 vs. 59.3; P= 0.001) and good adherence to medication (77.8% vs. 60.0%, P= 0.019). There was no significant difference regarding smoking between study groups. CONCLUSIONS: The clinical pharmacy‐led management programme can improve adherence, reduce the need for hospital care in patients with COPD and improve aspects of their HRQoL.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2125.2009.03493.x

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 145

Metadata

Authors
Khdour, M. R., Kidney, J. C., Smyth, B. M., & McElnay, J. C.
Venue
British Journal of Clinical Pharmacology
Publisher
Wiley
Published
2009-10
Volume
68
Issue
4
Pages
588-598
ISSN
  • 0306-5251 (ISSN-L)
  • 1365-2125
OpenAlex
W2084752662
Cited by
145
References
5
FWCI
1.78
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical pharmacy‐led disease and medicine management programme for patients with COPD. https://app.cochat.ai/papers/10.1111/j.1365-2125.2009.03493.x
The paper
Khdour, M. R., Kidney, J. C., Smyth, B. M., & McElnay, J. C. (2009). Clinical pharmacy‐led disease and medicine management programme for patients with COPD. British Journal of Clinical Pharmacology. https://doi.org/10.1111/j.1365-2125.2009.03493.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.